Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FTSJ1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
mRNA | PRH1-PRR4 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.004 |
mRNA | UBR3 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
mRNA | FGF9 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.004 |
mRNA | H3F3B | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
mRNA | AXL | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
mRNA | COL9A2 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.004 |
mRNA | GTF3C3 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.004 |
mRNA | FGF22 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
mRNA | AP3S1 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.004 |